Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Bluebird bio Inc (NASDAQ: BLUE) closed at $0.49 in the last session, up 0.88% from day before closing price of $0.49. In other words, the price has increased by $0.88 from its previous closing price. On the day, 3.18 million shares were traded. BLUE stock price reached its highest trading level at $0.5 during the session, while it also had its lowest trading level at $0.4835.
Ratios:
We take a closer look at BLUE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.68. In the meantime, Its Debt-to-Equity ratio is 7.37 whereas as Long-Term Debt/Eq ratio is at 3.67.
Morgan Stanley Upgraded its Underweight to Equal-Weight on December 08, 2023, whereas the target price for the stock was revised from $3 to $7.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 30 ’24 when Klima Thomas J sold 1,006 shares for $0.53 per share. The transaction valued at 529 led to the insider holds 170,000 shares of the business.
Obenshain Andrew sold 34,780 shares of BLUE for $18,270 on Sep 30 ’24. The President and CEO now owns 375,218 shares after completing the transaction at $0.53 per share. On Sep 30 ’24, another insider, Obenshain Andrew, who serves as the Officer of the company, bought 34,780 shares for $0.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 95172992 and an Enterprise Value of 346745792. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.73 while its Price-to-Book (P/B) ratio in mrq is 1.80. Its current Enterprise Value per Revenue stands at 6.316 whereas that against EBITDA is -1.148.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $5.53, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -16.60%, while the 200-Day Moving Average is calculated to be -50.58%.
Shares Statistics:
According to the various share statistics, BLUE traded on average about 7.34M shares per day over the past 3-months and 4592540 shares per day over the past 10 days. A total of 192.77M shares are outstanding, with a floating share count of 192.36M. Insiders hold about 0.80% of the company’s shares, while institutions hold 42.46% stake in the company. Shares short for BLUE as of 1727654400 were 48991273 with a Short Ratio of 6.68, compared to 1724976000 on 49371558. Therefore, it implies a Short% of Shares Outstanding of 48991273 and a Short% of Float of 27.38.
